ALVOTECH |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.5 USD | +1.97% |
|
+8.21% | +54.58% |
| 04-30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
| 04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- ALVO Stock
- ALVO Stock
- Revisions Alvotech
